对A型流感病毒广泛中和单克隆抗体:当前的见解和未来的方向
Nahed N Mahrous1, Ohoud S Alhumaidan2, Abdulaziz S Alkhoshaiban3
1Department of Biological Sciences, College of Science, University of Hafr Al-Batin, Hafr Al-Batin, Saudi Arabia.
单克隆抗体 (mAbs) 通过向病毒组件,提供有前途的流感A治疗. 进步加速了发展,但生产成本和阻力需要持续的监督和创新的可访问性战略.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 单克隆抗体 (mAbs) 是A型流感病毒 (IAV) 治疗和预防的有效工具.
- 生物技术的进步加速了对IAV有效的抗药物的开发.
研究的目的:
- 审查mAbs在增强流感A治疗中的潜力.
- 检查基于mAb的疗法的技术进步,临床性能和可扩展性.
主要方法:
- 关于mAb的发展和A型流感的临床应用现有文献的综述.
- 分析技术进步,包括混合瘤,菌体显示,B细胞永生化和人工智能驱动的设计.
- 对临床试验数据的评估和对安全性,疗效和耐药性模式的营销后监测.
主要成果:
- 通过减少病毒载量和疾病严重程度,mAbs在改善临床结果方面表现有希望,特别是在高风险人群中.
- 针对保存区域 (HA,NA) 的广泛中和抗体 (bnAbs) 对漂移变异有效.
- 挑战包括高生产成本,静脉注射和病毒逃生突变.
结论:
- 整合耐药监测,人工智能监测和计算建模对于有效和可访问的mAb疗法至关重要.
- 需要大规模生产和像吸入mAbs这样的替代交付方法来克服可访问性的障碍.
- mAbs代表了针对流感A的传统抗病毒药物的精确,适应性的替代品,有可能重新定义未来的治疗策略.
更多相关视频
12:09Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
Published on: November 22, 2017
07:15Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
Published on: November 22, 2021
相关概念视频
What are Viruses?
Acids, Bases and Neutralization Reactions
Acids, Bases and Neutralization Reactions
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Electrical Current
Bending of Curved Members - Neutral Surface
Consider the curved member described in the previous lesson. According to Hooke's law, which relates stress to strain within the...
